Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.
about
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosisFirst isolations of Segniliparus rugosus from patients with cystic fibrosisMPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections.Intra- and interpatient variability of the hsp65 and 16S-23S intergenic gene region in Mycobacterium abscessus strains from patients with cystic fibrosisNontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk.Clinical significance of microbial infection and adaptation in cystic fibrosis.Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival.Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis.Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis.Proposed definitions for epidemiologic and clinical studies of Mycobacterium avium complex pulmonary disease.Mycobacterium abscessus morphotype comparison in a murine model.Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients.Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis.Mycobacterium chimaera pulmonary infection complicating cystic fibrosis: a case report.Infection control in cystic fibrosis.Pediatrics, surfactant, and cystic fibrosis in AJRCCM 2003.Tuberculosis, lung infections, interstitial lung disease, social issues and journalology in AJRCCM 2003.Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic DiseaseIs limited computed tomography the future for imaging the lungs of children with cystic fibrosis?Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.New Real-Time PCR Assays for Detection of Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Group.Antiinflammatory therapies for cystic fibrosis: past, present, and future.Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.Evaluation and management of patients with pulmonary nontuberculous mycobacterial infections.Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City.Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel.Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosisChronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis.Update on antibiotics for infection control in cystic fibrosis.Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosisLung transplantation: infection, inflammation, and the microbiome.Current dilemmas in antimicrobial therapy in cystic fibrosis.Inhaled liposomal amikacin.Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis.Household proximity to water and nontuberculous mycobacteria in children with cystic fibrosis.Increasing Prevalence Rate of Nontuberculous Mycobacteria Infections in Five States, 2008-2013.Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis.Vaccine strategies against cystic fibrosis pathogens.Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis.
P2860
Q26775974-4FDDA27C-900F-4847-B32D-54D44A8DA20AQ31120557-2F37FA71-4BEC-467C-A8C7-A8B056BC611BQ33578979-C62A23AF-F38E-40F9-9D4E-D02E7430E980Q33885049-B4EB3053-228E-4122-8D88-890E36187A50Q34425805-94DCE56A-AB88-43A6-A398-63274557964BQ34491552-7F14DEE9-58CD-4792-98D2-1E5B4DCD4107Q34603485-6791609B-BA35-4CD3-B247-2816937AD8FEQ34610992-1F3E63CB-3898-42E8-95CC-24C2D4138A4BQ35005445-840F8BDC-D84C-44C8-A880-117C2C77D6AAQ35050258-D6B817D0-8050-4ACB-AE65-4B1BD7678526Q35078472-C600AA12-14B6-4284-B423-907D8BCF5230Q35094033-FF834AE5-5EF0-4455-9CF7-97EE70026785Q35213050-87D4D827-80CA-41B0-8F17-0098B161608DQ35298968-E40826D0-A4BF-4BFF-8500-2C9A19FDC2BBQ35545544-DABF666D-4786-4BA0-81F9-554417794443Q35626617-B87D0859-9FC6-498A-8956-A065822D8F17Q35626620-98D224C7-B2B7-4B63-ABE4-1BFF6722B2DEQ36128623-EB92979B-B217-4C8F-9580-ABA19A9D82E4Q36152917-9084DCCB-89A8-4BB7-A38B-53FE93A9679BQ36156072-09B9CC37-7214-4DF9-A7D6-FC9E7B1CA958Q36174064-919C9E87-E866-4D76-B818-56A998CFEEC2Q36174470-A8FF7DA9-6BEA-4059-A74D-A16941DBAD08Q36658777-512E30DE-21FB-4666-B038-C7FBDCBFF8FBQ36670892-686F0B60-7F2E-4A05-B3E9-190EF57911D4Q36688950-F9C386C2-F57D-4FBF-9F47-EBD82750DECCQ36944698-478AC1A8-5A73-4EFC-8996-E06C85D94692Q36944748-5FFA7606-644A-431F-8E25-6A9448CB0719Q36968540-1EC2B3B9-8353-4738-BD88-2F87BACE1116Q37334924-7F1AB91B-3141-4FDD-B929-7A384C0D72D5Q37608274-D4637E11-7DB0-4D50-ABA1-B1D630F34EE8Q37679780-79CA1B9F-4DC7-454F-9D55-843678C32D4EQ37832677-C71C600B-3F77-49F3-90E7-CB065EF0745EQ38042719-30046463-2334-4C1B-B91E-388C9E4B2150Q38216555-DC98D876-E8AC-43CE-AE8C-DA72ED69683BQ38749090-048F1B41-0BDD-4F4A-990A-B11196A62977Q38764394-666D44CE-DEF6-4FC4-A740-A201A0EECD4EQ39343316-E7FCC7FF-7FF5-4F5F-BFF3-B49791B5B38EQ40252432-F291BA0A-C7E3-43D9-8C6E-9FD6BE8FB1AEQ40262035-C8D27A52-4F6C-45AA-987C-ED72E773DD70Q41866799-F87858B5-475F-4BD8-A694-CC56869A9E3E
P2860
Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.
@en
Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.
@nl
type
label
Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.
@en
Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.
@nl
prefLabel
Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.
@en
Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.
@nl
P2093
P2860
P1476
Nontuberculous mycobacteria. I ...... cystic fibrosis lung disease.
@en
P2093
Allison Handler
David J Weber
Gail Tudor
Ji-Hyun Lee
Joseph Tomashefski
Kenneth N Olivier
Michael R Knowles
Nontuberculous Mycobacteria in Cystic Fibrosis Study Group
Paul L Molina
P2860
P304
P356
10.1164/RCCM.200207-679OC
P407
P577
2002-11-14T00:00:00Z